SCHEMBL3852227

SCHEMBL3852227

CS(=O)(=O)c1ccc(F)c(N2CCN(c3ncnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cc34)CC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 15/20 0.42
CYP1A2 P05177 13/20 0.42
CLK4 Q9HAZ1 11/20 0.42
ALDH1A1 P00352 11/20 0.42
HIF1A Q16665 11/20 0.42
MAPK1 P28482 9/20 0.42
LMNA P02545 9/20 0.42
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
USP2 O75604 8/20 0.40
CYP2D6 P10635 6/20 0.40
TSHR P16473 5/20 0.40
CYP2C19 P33261 5/20 0.40
ALOX15 P16050 2/20 0.40
NR1H2 P55055 1/20 0.39
NR1H3 Q13133 1/20 0.39
HSD17B10 Q99714 2/20 0.38
HPGD P15428 3/20 0.37
TP53 P04637 2/20 0.37
KDM4E B2RXH2 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852228 0.86 CYP3A4 (0.36) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3847513 0.86 CYP3A4 (0.42) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3845649 0.84 ACHE (0.45) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3852021 0.84 CYP3A4 (0.43) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3849227 0.81 CHRM4 (0.46) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3845891 0.80 ACHE (0.47) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
Hydrochloric Acid SCHEMBL3850590 0.78 AKT1 (0.49) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3846270 0.78 CYP3A4 (0.47) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3846795 0.78 CYP1A2 (0.59) CYP3A4CYP1A2CLK4ALDH1A1HIF1A
SCHEMBL3847121 0.77 MAPT (0.50) CYP3A4CYP1A2CLK4ALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed